ID PGFS2_BOVIN Reviewed; 323 AA. AC P52897; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-1996, sequence version 1. DT 16-JUN-2009, entry version 62. DE RecName: Full=Prostaglandin F synthase 2; DE Short=PGF synthase 2; DE Short=PGFS2; DE Short=PGF 2; DE EC=1.1.1.188; DE AltName: Full=Prostaglandin F synthase II; DE Short=PGFSII; DE AltName: Full=Prostaglandin-D2 11 reductase 2; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia; OC Pecora; Bovidae; Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Liver; RX MEDLINE=92231889; PubMed=1339268; DOI=10.1016/S0006-291X(05)80323-7; RA Kuchinke W., Barski O., Watanabe K., Hayaishi O.; RT "A lung type prostaglandin F synthase is expressed in bovine liver: RT cDNA sequence and expression in E. coli."; RL Biochem. Biophys. Res. Commun. 183:1238-1246(1992). CC -!- FUNCTION: Catalyzes the reduction of PGD(2) and PGH(2) to PGF(2 CC alpha) and a stereoisomer, respectively. It has a broad substrate CC specificity and reduces also other carbonyl compounds. CC -!- CATALYTIC ACTIVITY: (5Z,13E)-(15S)-9-alpha,11-alpha,15- CC trihydroxyprosta-5,13-dienoate + NADP(+) = (5Z,13E)-(15S)-9- CC alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADPH. CC -!- PATHWAY: Lipid metabolism; prostaglandin biosynthesis. CC -!- SUBUNIT: Monomer (By similarity). CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- SIMILARITY: Belongs to the aldo/keto reductase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; M86544; AAA30730.1; -; mRNA. DR IPI; IPI00701050; -. DR PIR; E75572; JH0575. DR RefSeq; XP_001250623.1; -. DR UniGene; Bt.64820; -. DR UniGene; Bt.66508; -. DR UniGene; Bt.67184; -. DR UniGene; Bt.91770; -. DR HSSP; P52895; 1J96. DR SMR; P52897; 2-323. DR Ensembl; ENSBTAG00000022570; Bos taurus. DR GeneID; 782922; -. DR KEGG; bta:782922; -. DR HOVERGEN; P52897; -. DR BRENDA; 1.1.1.188; 251. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0047017; F:prostaglandin-F synthase activity; IEA:EC. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0001516; P:prostaglandin biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR001395; Aldo/ket_red. DR InterPro; IPR018170; Aldo/ket_reductase_CS. DR Gene3D; G3DSA:3.20.20.100; Aldo/ket_red; 1. DR PANTHER; PTHR11732; Aldo/ket_red; 1. DR Pfam; PF00248; Aldo_ket_red; 1. DR ProDom; PD000288; Aldo/ket_red; 1. DR PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1. DR PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1. DR PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1. PE 2: Evidence at transcript level; KW Cytoplasm; Fatty acid biosynthesis; Lipid synthesis; NADP; KW Oxidoreductase; Prostaglandin biosynthesis. FT CHAIN 1 323 Prostaglandin F synthase 2. FT /FTId=PRO_0000124647. FT NP_BIND 13 22 NADP (Potential). FT NP_BIND 217 280 NADP (By similarity). FT ACT_SITE 55 55 Proton donor (By similarity). FT BINDING 117 117 Substrate (By similarity). FT SITE 84 84 Lowers pKa of active site Tyr (By FT similarity). SQ SEQUENCE 323 AA; 36742 MW; 21A5BE0668D07A2C CRC64; MDPKSQRVKF NDGHFIPVLG FGTYAPEEVP KSEALEATKF AIEVGFRHVD SAHLYQNEEQ VGQAIRSKIA DGTVKREDIF YTSKLWCNSL QPELVRPALE KSLQNLQLDY VDLYIIHSPV SLKPGNKFVP KDESGKLIFD SVDLCHTWEA LEKCKDAGLT KSIGVSNFNH KQLEKILNKP GLKYKPVCNQ VECHPYLNQS KLLEFCKSHD IVLVAYAALG AQLLSEWVNS NNPVLLEDPV LCAIAKKHKQ TPALVALRYQ VQRGVVVLAK SFNKKRIKEN MQVFDFELTP EDMKAIDGLN RNTRYYDFQQ GIGHPEYPFS EEY //